Similar to LAG3, TIM3 results in negative regulation of T cell response, ultimately leading to T cell exhaustion [57, 58], while its inhibition reduces tumor growth especially in combination with PD-1 blockade, but again the overall anti-tumor effect is modest [59]. Here, HAVCR2 is linked to neoplasm.